パチシラン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "パチシラン" in Japanese language version.

refsWebsite

Global rank Japanese rank

447^th place

1,043^rd place

79^th place

235^th place

719^th place

3,311^th place

68^th place

425^th place

99^th place

542^nd place

low place

low place

alnylam.com

Alnylam Japanプレスリリース

bloomberg.com

“Rare-Disease Treatment From Alnylam to Cost $450,000 a Year”. Bloomberg (10 August 2018). 11 August 2018閲覧。

europa.eu

ema.europa.eu

“Onpattro EPAR”. European Medicines Agency (EMA). 2 September 2020閲覧。

fda.gov

fda.gov

New Drug Therapy Approvals 2018 (PDF). U.S. Food and Drug Administration (FDA) (Report). January 2019. 2020年9月16日閲覧。
"FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease" (Press release). U.S. Food and Drug Administration (FDA). 10 August 2018. 2018年8月11日閲覧。

accessdata.fda.gov

“Drug Approval Package: Onpattro (patisiran)”. U.S. Food and Drug Administration (FDA) (7 September 2018). 2 September 2020閲覧。

medscape.com

“FDA OKs Patisiran (Onpattro) for Polyneuropathy in hAATR”. Medscape. WebMD (10 August 2018). 10 August 2018閲覧。

wsj.com

“New Kind of Drug, Silencing Genes, Gets FDA Approval”. The Wall Street Journal. (10 August 2018) 10 August 2018閲覧。